A New Era in RSV Prevention
A webinar sponsored by Sanofi.
August 29, 2024 | 2-3PM ET
Free for AMCP members and non-members.
- Understand RSV Burden in US infants and review RSV epidemiology.
- Review the pivotal nirsevimab clinical development studies establishing safety and efficacy and supporting ACIP recommendations.
- Discuss global real-world data for nirsevimab efficacy, effectiveness and impact on RSV outcomes and nirsevimab safety.
- Implementing Optimal Immunization Strategies to Help Reduce RSV LRTI
This webinar is only offered to payers, formulary committees, or other similar entities responsible for selecting drugs for coverage or reimbursement. To join this webinar, you must be registered as a user of FormularyDecisions®.
Related
An AMCP Webinar hosted by FormularyDecisions®
The product review process is complex and can vary between organizations. Join us as our expert panel outlines best practices for conducting a comprehensive product review. Our panel represents the managed care organization and biopharma company viewpoints to discuss current challenges and opportunities to streamline the product review process; including ways to incorporate digital tools.
During this sponsored webinar, we will overview Alzheimer's Disease (AD), discuss key considerations during the patient journey, and examine the potential impact of early intervention on the financial burden associated with AD.
Featured News & Resources
See Full CalendarUpcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
